Barbara Kiesel

3.6k total citations · 1 hit paper
92 papers, 2.2k citations indexed

About

Barbara Kiesel is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Barbara Kiesel has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 35 papers in Pulmonary and Respiratory Medicine and 25 papers in Biomedical Engineering. Recurrent topics in Barbara Kiesel's work include Glioma Diagnosis and Treatment (65 papers), Nanoplatforms for cancer theranostics (21 papers) and Brain Metastases and Treatment (17 papers). Barbara Kiesel is often cited by papers focused on Glioma Diagnosis and Treatment (65 papers), Nanoplatforms for cancer theranostics (21 papers) and Brain Metastases and Treatment (17 papers). Barbara Kiesel collaborates with scholars based in Austria, Germany and United States. Barbara Kiesel's co-authors include Georg Widhalm, Matthias Preusser, Adelheid Wöhrer, Christine Marosi, Anna S. Berghoff, Adelheid Wöehrer, Johannes A. Hainfellner, Engelbert Knosp, Stefan Wolfsberger and Orsolya Rajky and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Barbara Kiesel

87 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

2014 445 citations Anna S. Berghoff, Barbara Kiesel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Kiesel Austria	24	1.3k	569	564	504	383	92	2.2k
Maciej M. Mrugała United States	24	1.3k 1.0×	367 0.6×	233 0.4×	540 1.1×	442 1.2×	91	2.5k
Dana Cernea Romania	8	1.4k 1.1×	557 1.0×	224 0.4×	462 0.9×	313 0.8×	16	2.0k
Louisa von Baumgarten Germany	24	665 0.5×	719 1.3×	341 0.6×	861 1.7×	210 0.5×	80	2.5k
Alessandro Della Puppa Italy	32	1.5k 1.1×	516 0.9×	387 0.7×	543 1.1×	263 0.7×	172	3.2k
Joerg‐Christian Tonn Germany	29	1.7k 1.3×	687 1.2×	274 0.5×	620 1.2×	565 1.5×	111	3.6k
Clark C. Chen United States	29	693 0.5×	572 1.0×	397 0.7×	581 1.2×	200 0.5×	131	2.7k
Martin Glas Germany	28	1.5k 1.2×	635 1.1×	216 0.4×	501 1.0×	569 1.5×	151	2.6k
Arnold B. Etame United States	28	606 0.5×	876 1.5×	301 0.5×	874 1.7×	165 0.4×	92	2.4k
Courtney Kromer United States	5	1.4k 1.1×	505 0.9×	191 0.3×	344 0.7×	368 1.0×	6	2.5k
Jay‐Jiguang Zhu United States	25	1.0k 0.8×	345 0.6×	242 0.4×	294 0.6×	189 0.5×	88	1.7k

Countries citing papers authored by Barbara Kiesel

Since Specialization

Citations

This map shows the geographic impact of Barbara Kiesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Kiesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Kiesel more than expected).

Fields of papers citing papers by Barbara Kiesel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Kiesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Kiesel. The network helps show where Barbara Kiesel may publish in the future.

Co-authorship network of co-authors of Barbara Kiesel

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Kiesel. A scholar is included among the top collaborators of Barbara Kiesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Kiesel. Barbara Kiesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiesel, Barbara, Martin Borkovec, Julia Furtner, et al.. (2025). Sex-specific differences in DNA methylation defining prognostically relevant subgroups in glioblastoma. Journal of neurosurgery. 143(1). 204–213.

Reichert, David, Marco Andreana, Angelika Unterhuber, et al.. (2024). Analysis of the Porphyrin Peak Shift and Fluorescence Lifetime in Gliomas with Different Tumor Grades, Intratumoral Regions, and Visible Fluorescence Status. Diagnostics. 14(23). 2651–2651.

Roetzer-Pejrimovsky, Thomas, Karl‐Heinz Nenning, Barbara Kiesel, et al.. (2024). Deep learning links localized digital pathology phenotypes with transcriptional subtype and patient outcome in glioblastoma. GigaScience. 13. 5 indexed citations

Mischkulnig, Mario, David Reichert, Lionel Wightman, et al.. (2024). Detection of a Water-Soluble Hypericin Formulation in Glioblastoma Tissue with Fluorescence Lifetime and Intensity Using a Dual-Tap CMOS Camera System. Diagnostics. 14(21). 2423–2423. 1 indexed citations

Boele, Florien, Matthias Preusser, Émilie Le Rhun, et al.. (2024). Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectives. Neuro-Oncology Practice. 11(4). 484–493. 2 indexed citations

Steindl, Ariane, Arne Kienzle, Erwin Tomasich, et al.. (2023). 537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases. Annals of Oncology. 34. S405–S405. 1 indexed citations

Mischkulnig, Mario, Lisa I. Wadiura, Barbara Kiesel, et al.. (2023). Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment. PLoS ONE. 18(6). e0287993–e0287993. 3 indexed citations

Bergen, Elisabeth, Barbara Kiesel, Georg Widhalm, et al.. (2023). Brain metastases from hepatopancreatobiliary malignancies. Clinical & Experimental Metastasis. 40(2). 177–185. 4 indexed citations

Mischkulnig, Mario, Friedrich Erhart, Barbara Kiesel, et al.. (2022). Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization. Photodiagnosis and Photodynamic Therapy. 38. 102755–102755. 3 indexed citations

10.

Reichert, David, Johanna Gesperger, Lisa I. Wadiura, et al.. (2022). Improved Protoporphyrin IX-Guided Neurosurgical Tumor Detection with Frequency-Domain Fluorescence Lifetime Imaging. Applied Sciences. 12(3). 1002–1002. 3 indexed citations

11.

Wadiura, Lisa I., Barbara Kiesel, Thomas Roetzer-Pejrimovsky, et al.. (2022). Toward digital histopathological assessment in surgery for central nervous system tumors using stimulated Raman histology. Neurosurgical FOCUS. 53(6). E12–E12. 3 indexed citations

12.

Hosmann, Arthur, Matthias Millesi, Lisa I. Wadiura, et al.. (2021). 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers. 13(11). 2540–2540. 28 indexed citations

13.

Kiesel, Barbara, Lisa I. Wadiura, Mario Mischkulnig, et al.. (2021). Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years. Cancers. 13(23). 6119–6119. 7 indexed citations

14.

Hosmann, Arthur, Matthias Millesi, Lisa I. Wadiura, et al.. (2021). Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”. Cancers. 13(22). 5705–5705. 4 indexed citations

15.

Mischkulnig, Mario, Barbara Kiesel, Daniela Lötsch, et al.. (2021). Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas. Cancers. 13(4). 662–662. 5 indexed citations

16.

Mair, Maximilian J., Aysegül Ilhan‐Mutlu, Ariane Steindl, et al.. (2020). Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. ESMO Open. 5(6). e000863–e000863. 16 indexed citations

17.

Kiesel, Barbara, Matthias Millesi, Adelheid Wöehrer, et al.. (2018). 5-ALA–induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. Neurosurgical FOCUS. 44(6). E7–E7. 44 indexed citations

18.

Kiesel, Barbara, Adelheid Wöhrer, Mauricio Martínez-Moreno, et al.. (2015). Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas. Neurosurgical FOCUS. 38(1). E4–E4. 35 indexed citations

19.

Millesi, Matthias, Barbara Kiesel, Adelheid Wöehrer, et al.. (2014). Analysis of 5-aminolevulinic acid–induced fluorescence in 55 different spinal tumors. Neurosurgical FOCUS. 36(2). E11–E11. 51 indexed citations

20.

Minchev, Georgi, Gernot Kronreif, Luther H. Holton, et al.. (2013). Application of the ISYS1 robotic device for stereotactic neurosurgical interventions: a preclinical phantom trial.. 88–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact